Browse > Article

Inhibition of Vascular Endothelial Growth Factor-induced Endothelial Cell Differentiation by Intravenous Immunoglobulin and Methylprednisolone  

Choi, Hyoun Ah (Department of Pediatrics, College of Medicine, The Catholic University of Korea)
Ha, Kyung Hwa (Department of Pediatrics, College of Medicine, The Catholic University of Korea)
Yoon, Jong Seo (Department of Pediatrics, College of Medicine, The Catholic University of Korea)
Lee, Yoon (Department of Pediatrics, College of Medicine, The Catholic University of Korea)
Lee, Joon Sung (Department of Pediatrics, College of Medicine, The Catholic University of Korea)
Han, Ji Wwan (Department of Pediatrics, College of Medicine, The Catholic University of Korea)
Publication Information
Clinical and Experimental Pediatrics / v.48, no.8, 2005 , pp. 886-893 More about this Journal
Abstract
Purpose : Kawasaki disease is the most common cause of systemic vasculitis in children less than 5 years of age. Recent immunohistochemistry findings suggest that many vascular growth factors play a role in the formation of the coronary artery lesions. Active remodeling of the coronary artery lesions in Kawasaki disease continues in the form of intimal proliferation and neoangiogenesis for several years after the onset of the disease. Intravenous immunoglobulin(IVIG) and corticosteroid have been used in the treatment of Kawasaki disease but the exact mechanism is not clear. We have investigated that IVIG and corticosteroid inhibited vascular endothelial growth factor(VEGF)-induced tube formation of endothelial cells in vitro on Matrigel assay. Methods : Human umbilical vein endothelial cells(HUVECs) were cultured and seeded on Matrigel coated 24 well plates in medium with or without the following agents : VEGF, VEGF plus IVIG, VEGF plus VEGF antibody, VEGF plus methylprednisolone, VEGF, IVIG plus methylprednisolone for 18 hours. The total length of tube structures in each photograph was quantified. Results : IVIG significantly inhibited the proliferation of HUVECs. The inhibitory effect of IVIG was also reversible. In the meantime, VEGF induced the differentiation of HUVECs into capillary like structures on Matrigel, which was inhibited by VEGF antibody in a dose-dependent manner. Interestingly, IVIG and methylprednisolone inhibited VEGF-induced tube formation of HUVECs. IVIG was more effective in inhibition than methylprednisolone alone. Conclusion : We revealed that VEGF induced the differentiation of HUVECs and this effect was inhibited by IVIG and methylprednisolone.
Keywords
Endothelial cell; Vascular endothelial growth factor(VEGF); Intravenous immunoglobulin(IVIG); Methylprednisolone;
Citations & Related Records
연도 인용수 순위
  • Reference
1 Leung DW, Cachianes G, Kuang WJ, Goeddel DV, Ferrara N. Vascularendothelial growth factor is a secreted angiogenic mitogen. Science 1989;246:1306-9   DOI   PUBMED
2 Koch AE, Harlow LA, Haines GK, Amento EP, Unemori EN, Wong WL, et al. Vascular endothelial growth factor. A cytokine modulating endothelial function in rheumatoid arthritis. J Immunol 1994;152:4149-56
3 Ferrara N. Vascular endothelial growth factor. Eur J Cancer 1996;32A:2413-22
4 Folkman J, Langer R, Linhardt RJ, Haudenschild C, Taylor S. Angiogenesis inhibition and tumor regression caused by heparin or a heparin fragment in the presence of cortisone. Science 1983;221:719-25   DOI   PUBMED
5 Trautmann A, Akdis M, Schmid-Grendelmeier P, Disch R, Broker EB, Blaser K, et al. Targeting keratinocyte apoptosis in the treatment of atopic dermatitis and allergic contact dermatitis. J Allergy Clin Immunol 2001;108:839-46   DOI   ScienceOn
6 Breier G, Albrecht U, Sterrer S, Risau W. Expression of vascular endothelial growth factor during embryonic angiogenesis and endothelial cell differentiation. Development 1992;114:521-32
7 Maeno N, Takei S, Masuda K, Akaike H, Matsuo K, Kitajima I, et al. Increased serum levels of vascular endothelial growth factor in Kawasaki disease. Pediatr Res 1998;44:596-9   DOI   ScienceOn
8 Li J, Brown LF, Hibberd MG, Grossman JD, Morgan JP, Simons M. VEGF, flk-1, and flt-1 expression in a rat myocardial infarction model of angiogenesis. Am J Physiol 1996;270:H1803-11
9 Shinohara M, Sone K, Tomomasa T, Morikawa A. Corticosteroids in the treatment of the acute phase of Kawasaki disease. J Pediatr 1999;135:465-9   DOI   ScienceOn
10 Segura I, Serrano A, Buitrago GG, Gonzalez MA, Abad JL, Claveria C, et al. Inhibition of programmed cell death impairs in vitro vascular-like structure formation and reduces in vivo angiogenesis. FASEB J 2002;16:833-41.   DOI   ScienceOn
11 Dvorak HF, Brown LF, Detmar M, Dvorak AM. Vascular permeability factor/vascular endothelial growth factor, microvascular hyperpermeability, and angiogenesis. Am J Pathol 1995;146:1029-39
12 Tilton RG, Kawamura T, Chang KC, Ido Y, Bjercke RJ, Stephan CC, et al. Vascular dysfunction induced by elevated glucose levels in rats is mediated by vascular endothelial growth factor. J Clin Invest 1997;99:2192-202   DOI   ScienceOn
13 Rowely AH, Shulman ST, Mask CA, Finn LS, Terai M, Baker SC, et al. Ig A plasma cell infiltration of proximal respiratory tract, pancreas, kidney, and coronary artery in acute Kawasaki disease. J Infect Dis 2000;182:1183-91   DOI   ScienceOn
14 Ferrara N, Houck K, Jakeman L, Leung DW. Molecular and biological properties of the vascular endothelial growth factor family of proteins. Endocr Rev 1992;13:18-32
15 Terai M, Honda T, Yasukawa K, Higashi K, Hamada H, Kohno Y. Prognostic impact of vascular leakage in acute Kawasaki disease. Circulation 2003;108:325-30   DOI   ScienceOn
16 Klagsbrun M, D'Amore PA. Vascular growth factor and its receptors. Cytokine Growth Factor Rev 1996;7:259-70   DOI   ScienceOn
17 Suzuki A, Miyagawa-Tomita S, Komatsu K, Nishikawa T, Sakomura Y, Horie T, et al. Active remodeling of the coronary arterial lesions in the late phase of Kawasaki disease : immunohistochemical study. Circulation 2000;101:2935- 41   DOI   ScienceOn
18 Fava RA, Olsen NJ, Spencer-Green G, Yeo KT, Yeo TK, Berse B, et al. Vascular permeability factor/endothelial growth factor(VPF/VEGF) : accumulation and expression in human synovial fluids and rheumatoid synovial tissue. J Exp Med 1994;180:341-6   DOI
19 Hashimoto E, Ogita T, Nakaoka T, Matsuoka R, Takao A, Kira Y. Rapidinduction of vascular endothelial growth factor expression by transient ischemia in rat heart. Am J Physiol 1994;267:H1948-54
20 Leung DY. Kawasaki disease. Curr Opin Rheumatol 1993; 5:41-50   DOI   PUBMED   ScienceOn
21 Plate KH, Breier G, Weich HA, Risau W. Vascular endothelial growth factor is a potential tumour angiogenesis factor in human gliomas in vivo. Nature 1992;359:845-8   DOI   ScienceOn
22 Freeman AF, Shulman ST. Recent developments in Kawasaki disease. Curr Opin Infect Dis 2001;14:357-61   DOI   ScienceOn
23 Nagashima M, Yoshino S, Ishiwata T, Asano G. Role of vascular endothelial growth factor in angiogenesis of rheumatoid arthritis. J Rheumatol 1995;22:1624-30
24 Baatout S. Endothelial differentiation using Matrigel(review). Anticancer Res 1997;17:451-5
25 Abe Y, Horiuchi A, Miyake M, Kimura S. Anti-cytokine nature of natural human immunoglobulin : one possible mechanism of the clinical effect of intravenous immunoglobilin therapy. Immunol Rev 1994;139:5-19   DOI   PUBMED   ScienceOn
26 Dale RC, Saleem MA, Daw S, Dillon MJ. Treatment of severe complicated Kawasaki disease with oral prednisolone and aspirin. J Pediatr 2000;137:723-6   DOI   ScienceOn
27 Suzuki A, Miyagawa-Tomita S, Nakazawa M, Yutani C. Remodeling of coronary artery lesions due to Kawasaki disease : comparison of arteriographic and immunohistochemical findings. Jpn Heart J 2000;41:245-56   DOI   ScienceOn
28 Savage CO, Cooke SP. The role of endothelium in systemic vasculitis. J Autoimmun 1993;6:237-49   DOI   ScienceOn